purpos
sever
ard
often
associ
refractori
hypoxemia
earli
identif
treatment
hypoxemia
mandatori
manag
sever
ard
ventil
set
posit
therapi
infect
control
support
measur
essenti
improv
surviv
precis
definit
lifethr
hypoxemia
identifi
typic
clinic
determin
arteri
partial
pressur
oxygen
mmhg
andor
arteri
oxygen
andor
ratio
pao
fio
mechan
ventil
specif
set
recommend
limit
tidal
volum
ml
kg
predict
bodi
weight
adequ
high
peep
cmh
recruit
manoeuvr
special
situat
balanc
respiratori
rate
individu
bedsid
method
guid
peeprecruit
eg
transpulmonari
pressur
yet
avail
prone
posit
earli
hr
onset
sever
ard
prolong
repetit
improv
surviv
advanc
infect
managementcontrol
includ
earli
diagnosi
bacteri
atyp
viral
fungal
specimen
blood
cultur
bronchoalveolar
lavag
infect
sourc
ct
scan
follow
administr
broadspectrum
antiinfect
neuromuscular
blockag
cisatracurium
hr
onset
ard
well
adequ
sedat
strategi
score
guid
import
support
therapi
neg
fluid
balanc
associ
improv
lung
function
use
hemofiltr
might
indic
specif
indic
specif
standard
care
requir
manag
sever
ard
refractori
hypoxemia
acut
respiratori
distress
syndrom
ard
character
lifethreaten
impair
pulmonari
ga
exchang
result
hypoxemia
hypercapnia
respiratori
acidosi
requir
acut
rescu
measur
oxygen
deliveri
tissu
necessari
aerob
life
tissu
hypoxia
result
variou
deleteri
effect
includ
alter
vascular
reactiv
inflamm
cell
apoptosi
organ
dysfunct
failur
tissu
hypoxia
result
hypoxemia
hypoxemia
consequ
insuffici
support
respiratori
system
andor
oxygen
deliveri
system
cardiac
output
hemoglobin
level
unfortun
precis
simpl
limit
area
hypoxemia
identifi
critic
level
harm
appear
might
vari
organ
patient
furthermor
known
whether
critic
ill
patient
spectrum
compensatori
mechan
hypoxemia
normal
human
bodi
rapid
onset
acclimat
effect
sever
durat
hypoxemia
may
determin
induct
tissu
hypoxia
clinic
determin
hypoxemia
vari
typic
valu
arteri
partial
pressur
oxygen
pao
mmhg
ratio
pao
fio
arteri
oxygen
puls
oximetri
sao
recent
year
strategi
permiss
hypoxemia
sao
patient
sever
ard
propos
aim
minim
harm
effect
high
inspiratori
oxygen
concentr
accept
low
sao
optim
cardiac
output
maintain
adequ
oxygen
deliveri
note
classic
concept
oxygen
deliveryconsumpt
depend
controversi
recent
cochran
review
fail
identifi
relev
studi
evalu
hypoxemia
versu
normoxemia
ventil
patient
ard
furthermor
retrospect
analysi
ard
patient
lower
pao
mechan
ventil
median
mmhg
associ
higher
incid
longterm
cognit
impair
psychiatr
disord
compar
higher
pao
median
mmhg
p
hypoxemia
tissu
hypoxia
could
detect
pao
sao
serum
lactat
central
venou
oxygen
satur
svo
global
measur
extent
flowvolumeaverageweight
measur
reflect
organ
hypoxia
remain
unknown
clinic
practic
definit
hypoxemia
often
base
one
global
valu
current
paramet
precis
assess
tissu
hypoxia
individu
patient
avail
sinc
inadequ
tissu
oxygen
well
excess
oxygen
administr
express
oxygen
reactiv
speci
harm
care
balanc
base
precis
control
arteri
oxygen
includ
accept
safe
threshold
may
avoid
deleteri
hypoxia
well
hyperoxiaassoci
injuri
remain
evalu
studi
whether
select
biomark
may
help
identifi
tissu
hypoxia
individu
patient
summari
simpl
global
paramet
pao
sao
svo
lactat
imprecis
surrog
hypoxia
ard
patient
howev
individu
organspecif
approach
monitor
hypoxemia
current
avail
therefor
target
conserv
arteri
oxygen
recommend
pao
mmhg
sao
bundl
gener
organ
failur
prevent
strategi
low
v
ventil
mlkg
predict
bodi
weight
pbw
reduc
total
hospit
mortal
pbwbase
v
ignor
lung
volum
actual
avail
ventil
appli
volum
distribut
aerat
region
larger
nonaer
region
greater
associ
hyperinfl
strain
drive
pressur
given
v
respons
open
lung
area
collaps
endexpir
lower
pressur
reopen
area
hypoxemia
worsen
solut
increas
peep
order
reap
potenti
benefit
protect
approach
especi
sever
ard
also
reduc
drive
pressur
requir
would
allow
individu
set
base
physiolog
measur
consider
whether
pressurecontrol
ventil
pcv
reduc
ventilatorassoci
lung
injuri
vali
compar
volumecontrol
vcv
ventil
matter
debat
metaanalysi
three
random
control
trial
rct
conclud
pcv
superior
vcv
rel
risk
hospit
icu
mortal
pcv
versu
vcv
ci
p
ci
p
respect
anoth
systemat
review
includ
studi
conclud
outcom
unlik
influenc
simpli
use
one
breath
type
vs
patient
sinc
flow
drive
pressur
frequenc
determin
power
factor
ventil
injur
lung
seem
unlik
manner
power
deliv
ie
flow
pattern
play
major
role
airway
pressur
releas
ventil
provid
potenti
recruit
increas
airway
pressur
allow
spontan
breath
potenti
benefit
decreas
sedat
shorter
mechan
ventil
improv
cardiac
perform
highfrequ
oscillatori
ventil
deliv
small
tidal
volum
prevent
volutrauma
constant
rel
high
mean
airway
pressur
despit
theoret
benefit
clinic
evid
techniqu
remain
unproven
controversi
ard
patient
effect
respiratori
rate
rr
occurr
vali
outcom
ard
independ
studi
lung
injuri
may
relat
frequenc
repetit
collaps
expans
ie
often
lung
expos
given
stress
strain
degre
tissu
damag
probabl
depend
pressur
amplitud
lesser
extent
frequenc
appli
howev
higher
respiratori
rate
might
prevent
expiratori
derecruit
reduc
expiratori
time
caus
intrins
peep
larg
anim
model
vali
higher
rr
associ
less
pulmonari
inflamm
increas
lung
edema
accordingli
high
rr
might
influenc
amount
extrins
peep
current
statu
lung
term
de
recruit
region
complianc
resist
increas
inspiratori
time
suggest
improv
oxygen
effect
high
e
ratio
hypoxem
ard
patient
relat
result
increas
intrins
peep
peepi
improv
ventil
unit
long
time
constant
alveolar
recruit
secondari
increas
mean
airway
pressur
paw
result
regard
effect
differ
e
ratio
conflict
report
posit
effect
ascrib
shorten
expiratori
time
increas
paw
peepi
use
extrins
peep
perhap
physiolog
approach
maintain
control
constant
level
moreov
impact
inconst
peepi
stressstrain
time
product
pathogenesi
vali
call
caution
heat
humidifi
inspiratori
ga
heat
humidifi
heat
moistur
exchang
compens
bypass
humidificationh
mechan
prevent
associ
complic
heat
moistur
exchang
wide
use
low
cost
simpl
handl
condens
elimin
breath
circuit
howev
increas
dead
space
airway
resist
well
work
breath
assist
ventil
risk
hypercapnia
ard
patient
heat
humidifi
heat
moistur
exchang
safe
reduc
paco
without
chang
ventil
set
acut
lung
injuri
ali
ard
patient
v
significantli
reduc
use
heat
humidifi
find
question
use
heat
moistur
exchang
ard
patient
primari
target
provid
optimum
lungprotect
ventil
alveolar
recruit
obtain
posit
endexpiratori
pressur
peep
andor
lung
recruit
maneuv
lrm
use
improv
hypoxemia
patient
ard
sinc
earli
first
descript
syndrom
present
aim
alveolar
recruit
improv
oxygen
also
prevent
vali
minim
tidal
alveolar
open
collaps
atelectrauma
howev
despit
myriad
clinic
translat
studi
three
larg
clinic
trial
effect
recruit
remain
controversi
one
simpl
reason
clinician
lack
bedsid
method
quantifi
alveolar
recruit
impact
vili
henc
decis
base
surrog
arteri
oxygen
endinspiratori
plateau
pressur
drive
pressur
electr
imped
tomographi
eit
lung
ultrasound
stress
index
propos
monitor
alveolar
recruit
seldom
use
clinic
practic
present
evidencebas
protocol
set
peep
one
propos
ard
network
ardsnet
pivot
studi
howev
studi
peep
fio
combin
control
studi
arm
lrm
permit
overal
ardsnet
protocol
toler
atelectasi
appli
minim
peep
fio
match
accept
rather
low
arteri
oxygen
target
mmhg
nevertheless
two
major
issu
remain
controversi
prevent
main
vili
mechan
tidal
recruit
hyperinfl
best
rescu
protocol
adopt
ardsnet
protocol
fail
ie
oxygen
target
reach
within
peepfio
andor
inspiratori
plateau
pressur
limit
impos
protocol
overal
side
effect
complic
associ
mechan
ventil
summar
tabl
metaanalysi
three
major
clinic
trial
evalu
first
issu
suggest
applic
lrm
peep
level
higher
suggest
ardsnet
protocol
could
improv
lung
aerat
clinic
outcom
second
issu
major
clinic
challeng
small
neglig
cohort
patient
first
approach
persist
sever
hypoxemia
prone
posit
neuromuscular
blockad
adequ
improv
oxygen
patient
candid
rescu
maxim
alveolar
recruit
simplest
though
smart
open
lung
approach
one
propos
express
studi
exclus
dedic
rescu
patient
briefli
consist
stepwis
peep
increas
endinspiratori
plateau
pressur
cmh
cmh
impair
chest
wall
elast
like
ventil
low
tidal
volum
v
ie
mlkg
pbw
lrm
mandatori
express
protocol
howev
difficult
ventil
patient
strongli
advis
peep
titrat
anoth
import
approach
though
seldom
appli
clinic
practic
optim
transpulmonari
pressur
p
l
inde
peep
lrm
drive
pressur
deliv
ventil
consist
two
compon
one
inflat
lung
p
l
one
expand
chest
wall
simultan
measur
airway
open
esophag
pressur
swing
gener
posit
pressur
tidal
inflat
allow
partit
mechan
properti
lung
chest
wall
accordingli
peep
lrm
titrat
safe
optim
p
l
target
recent
evid
suggest
could
improv
refractori
hypoxemia
aggress
open
lung
approach
propos
barba
et
al
base
physiolog
evid
alveolar
recruit
multiinspiratori
phenomenon
critic
open
pressur
atelectat
lung
unit
higher
pressur
need
keep
open
barba
et
al
propos
titrat
peep
expiratori
limb
respiratori
volumepressur
curv
match
best
complianc
best
oxygen
immedi
maxim
lrm
latter
consist
stepwis
peep
increas
cmh
ventil
patient
pressur
drive
cmh
open
lung
approach
may
dramat
improv
oxygen
minim
vali
potenti
alveolar
recruit
individu
patient
unfortun
extrem
variabl
difficult
estim
priori
gener
rule
patient
earli
diffus
ard
good
recruit
wherea
patient
late
ard
week
focal
ard
poor
recruit
open
lung
approach
may
induc
alveolar
hyperinfl
henc
vali
stress
index
identif
injuri
mechan
ventil
shape
pressurevolum
curv
could
valuabl
tool
monitor
open
lung
approachinduc
hyperinfl
anoth
potenti
advers
effect
open
lung
approach
hemodynam
impair
due
reduc
preload
increas
right
ventricular
afterload
prone
posit
ventil
consist
deliv
mechan
ventil
patient
turn
facedown
method
frequent
sometim
markedli
improv
oxygen
patient
ard
treatment
prone
posit
ventil
result
significantli
better
oxygen
mechan
ventil
appli
supin
posit
ard
patient
prone
posit
use
import
strategi
lifethreaten
hypoxemia
avoid
seriou
advers
event
death
due
sever
hypoxemia
individu
patientdata
fibroprolif
respons
lung
parenchyma
lungprotect
era
decrement
lung
function
vital
capac
forc
expiratori
volum
year
discharg
metaanalysi
four
larg
rct
prone
posit
associ
significantli
better
surviv
rate
ard
patient
pao
fio
mmhg
howev
recent
trial
show
significantli
better
surviv
prone
posit
group
compar
supin
posit
patient
moder
sever
ard
benefit
prone
observ
level
hypoxemia
time
random
correl
found
magnitud
oxygen
respons
first
session
patient
surviv
therefor
benefici
effect
prone
like
explain
factor
improv
oxygen
among
prevent
vali
like
major
contribut
factor
benefit
prone
appli
firstlin
therapi
patient
moder
sever
ard
stress
effect
prone
vili
prevent
distinct
effect
oxygen
henceforth
prone
appli
earli
possibl
identif
hypoxem
ard
make
lung
homogen
reduc
stress
strain
impos
entir
lung
mechan
ventil
proseva
trial
howev
patient
enrol
stabil
period
use
confirm
ard
like
strategi
led
select
patient
recruit
heterogen
lung
would
benefit
prone
nevertheless
control
group
disfavor
mortal
exactli
anoth
trial
similar
patient
earli
trial
use
prone
session
turn
use
longer
session
last
h
feasibl
proseva
trial
mean
session
durat
h
prone
treatment
use
day
averag
psii
trial
valu
h
day
respect
criterion
stop
prone
defin
proseva
trial
improv
oxygen
last
h
supin
posit
pao
fio
mmhg
peep
cmh
fio
psii
trial
prone
posit
stop
acut
respiratori
failur
resolv
pao
fio
supin
similar
prone
posit
two
strategi
result
differ
dose
prone
amount
respect
time
alloc
prone
actual
spent
posit
interest
note
mani
center
use
prone
posit
mani
year
procedur
simpl
done
routin
caregiv
center
prone
patient
frequent
procedur
describ
complex
cumbersom
riski
stress
procedur
realli
need
specif
implement
program
icu
like
techniqu
volum
effect
matter
last
metaanalys
trial
prone
versu
supin
posit
pressur
sore
endotrach
tube
obstruct
still
significantli
frequent
prone
also
stress
trial
show
harm
effect
prone
posit
group
specif
contraind
prone
defin
trial
like
singl
absolut
contraind
unstabl
spine
fractur
contraind
tabl
rel
benefittorisk
balanc
favor
prone
worth
note
tabl
acut
abdomen
contraind
prone
posit
earli
phase
ard
time
admiss
ard
center
lung
whole
bodi
comput
tomographi
ct
may
perform
especi
combin
sepsi
ardsif
indic
support
care
anamnesi
clinic
histori
examinationto
diagnos
focu
infect
major
caus
ard
b
typic
complic
ard
c
concomit
disord
requir
therapeut
intervent
risk
factor
extracorpor
lung
support
ct
perform
detect
sever
causal
agent
infect
pulmonari
infiltr
ground
glass
opac
pleural
effus
pleural
empyema
lung
abscess
lymphadenopathi
cerebr
abscess
cerebr
septic
embolu
intraabdomin
abscess
infect
transesophag
echocardiographi
use
exclud
endocard
pericardi
effus
assess
right
left
ventricular
function
flexibl
bronchoscopi
use
diagnostictherapeut
procedur
hypoxemia
hypercapnia
may
occur
bronchoscopi
sever
hypoxemia
pao
fio
might
seen
contraind
bronchoalveolar
lavag
bal
protect
specimen
brush
use
rare
costli
dispos
major
caus
ard
infect
blood
cultur
bc
pair
ml
blood
volum
steril
condit
antiinfect
treatment
essenti
clinic
diagnost
specif
antiinfect
strategi
base
cultur
result
effect
compar
empir
broadspectrum
treatment
new
techniqu
eg
polymeras
chain
reaction
pcr
deoxyribonucl
acid
dna
amplif
microarray
andor
matrixassist
laser
desorptionion
maldi
shorten
total
run
time
less
h
avail
tracheobronchi
secret
investig
use
quantit
bal
ml
nacl
mininonbronchoscop
bal
ml
nacl
especi
hypoxem
situat
bronchoscopyguid
bal
might
invas
cutoff
signific
number
coloni
form
unit
differenti
colon
infect
depend
diagnost
test
tracheobronchi
secret
cfu
ml
bal
cfuml
protect
specimen
brush
cfuml
gramstain
still
recommend
sinc
patient
without
antiinfect
treatment
high
neg
predict
valu
document
exclus
atyp
pneumonia
legionella
antigen
assess
urin
sputum
two
neg
test
recommend
new
molecular
assay
part
panel
viral
pneumonia
influenza
two
subtyp
parainfluenza
atyp
pathogen
short
run
time
avail
icu
patient
influenzaassoci
pneumonia
risk
bacteri
coinfect
delay
treatment
season
influenza
influenzaassoci
infect
report
tabl
note
care
examin
may
help
exclud
clinic
entiti
mistaken
ard
eg
idiopath
pulmonari
fibrosi
cryptogen
organ
pneumonia
nonspecif
interstiti
pneumon
wegen
granulomatosi
acut
eosinophil
pneumonia
diseas
need
cours
lungprotect
strategi
limit
v
ardsspecif
measur
address
articl
proven
may
automat
help
variou
diagnost
tool
bal
analysi
hemogram
cytolog
flow
cytometr
analysi
describ
complet
diagnost
workup
immunosuppress
patient
specif
diagnost
therapeut
procedur
essenti
pretreat
antiinfect
local
resist
sever
ill
organ
failur
consid
calcul
use
broadspectrum
antibiot
target
treatment
success
detect
respons
pathogen
effect
lower
mortal
moreov
deescal
target
antiinfect
treatment
pneumonia
reduc
superinfect
resist
pathogen
diagnos
sepsi
result
invas
candidiasi
earli
bc
laboratori
examin
eg
recommend
open
lung
biopsi
perform
demonstr
presenc
diffus
alveolar
damag
consid
high
clinic
suspicion
contribut
result
riski
empir
therapi
empir
therapi
fail
immunosuppress
patient
high
risk
invas
pulmonari
aspergillosi
patient
bal
galactomannan
level
ctsuspect
area
sensit
specif
serum
new
diagnost
method
use
later
flow
devic
might
enabl
bedsid
diagnos
futur
conclus
ard
patient
suspect
infect
candid
advanc
broadspectrum
antibiot
obtain
bc
fiber
bronchoscopi
result
daili
reassess
deescal
recommend
ard
patient
pao
fio
ratio
lower
mmhg
earli
treatment
continu
infus
cisatracurium
h
reduc
mortal
barotrauma
increas
number
ventilatorfre
day
number
day
outsid
icu
without
increas
risk
icuacquir
weak
precis
mechan
result
improv
outcom
clear
term
lung
mechan
better
synchroni
may
lead
moreuniform
lung
recruit
improv
complianc
ga
exchang
system
oxygen
respect
lung
inflamm
plausibl
improv
control
inspiratori
volum
pressur
reduc
volutrauma
better
control
expiratori
volum
pressur
reduc
atelectrauma
result
less
pulmonari
system
inflamm
accord
studi
protocol
clinician
monitor
depth
paralysi
peripher
nerv
stimul
rather
plateau
pressur
exceed
cmh
min
despit
increas
sedat
intraven
bolu
cisatracurium
administ
outcom
benefit
rescu
therapi
neuromuscular
blockad
applic
cisatracurium
besyl
neuromuscular
block
agent
optim
dose
monitor
strategi
need
studi
sedat
manag
earli
phase
ard
manag
accord
need
neuromuscular
block
agent
promot
lungprotect
ventil
random
trial
suggest
clinic
advantag
particular
sed
howev
propens
score
analysi
larg
multicent
icu
databas
suggest
benzodiazepin
infus
independ
associ
higher
mortal
longer
durat
icu
stay
ventil
support
compar
propofol
ard
patient
meet
criteria
continu
muscl
paralysi
soon
neuromuscular
block
agent
longer
requir
clinician
target
light
sedat
frequent
assess
pain
sedat
use
valid
scale
sedat
manag
accord
approach
propos
guidelin
manag
pain
agit
delirium
random
trial
mehta
colleagu
found
daili
sedat
interrupt
dsi
provid
addit
benefit
nursedirect
sedat
protocol
use
systemat
review
nine
trial
patient
also
conclud
strong
evid
dsi
alter
durat
mechan
ventil
mortal
length
icu
hospit
stay
although
evid
light
sedat
mechan
ventil
critic
ill
patient
like
enhanc
futur
data
regard
sedat
manag
patient
sever
hypoxemia
critic
situat
deep
sedat
within
h
onset
might
advantag
despit
signific
improv
oxygen
inhal
nitric
oxid
ino
reduc
mortal
patient
ard
regardless
sever
hypoxemia
may
increas
risk
renal
impair
recent
metaanalysi
includ
nine
random
trial
n
patient
betweentri
heterogen
show
ino
reduc
mortal
patient
sever
ard
risk
ratio
ci
mildmoder
ard
risk
ratio
ci
moreov
analysi
pao
fio
ratio
subgroup
rang
mmhg
identifi
threshold
ino
reduc
mortal
effect
safeti
cost
inhal
epoprostenol
iepo
versu
ino
address
retrospect
singlecent
studi
patient
betweengroup
differ
sever
clinic
outcom
paramet
conserv
fluid
manag
ard
use
furosemid
associ
improv
lung
function
reduc
durat
mechan
ventil
without
increas
nonpulmonari
organ
failur
although
signific
differ
primari
outcom
mortal
furthermor
singlecent
studi
suggest
earli
treatment
hemofiltr
rescu
treatment
patient
ard
may
reduc
cytokin
level
system
inflammatori
respons
improv
cardiac
function
decreas
extravascular
lung
water
index
associ
improv
outcom
howev
larger
trial
need
singlecent
trial
publish
chines
found
patient
random
continu
highvolum
hemofiltr
better
oxygen
reduc
durat
mechan
ventil
improv
surviv
compar
standard
care
incid
gastrointestin
stress
bleed
intens
care
patient
low
prognost
import
ambigu
gastrointestin
stress
bleed
prophylaxi
wide
use
icu
worldwid
systemat
review
demonstr
suffici
evid
use
prophylaxi
low
earli
low
dose
glucocorticoid
gc
methylprednisolon
mg
kgday
dose
taper
might
acceler
resolut
ard
could
contribut
reduct
mortal
without
risk
increas
infect
still
controversi
discuss
deep
vein
thromboembol
dve
prophylaxi
routin
measur
immobil
icu
patient
ard
patient
recommend
similar
patient
group
daili
unfraction
low
molecular
weight
heparin
given
dve
prophylaxi
accord
institut
algorithm
includ
contraind
mode
applic
subcutan
continu
via
venou
rout
ecmo
patient
specif
strategi
term
anticoagul
mandatori
backrest
elev
posit
prefer
supin
posit
ard
patient
sinc
may
contribut
improv
oxygen
respiratori
mechan
compar
flat
supin
limit
backrest
elev
eg
hemodynam
impair
must
consid
sever
ard
often
associ
refractori
hypoxemia
earli
identif
treatment
mandatori
howev
simpl
definit
lifethr
hypoxemia
identifi
specif
ventil
set
compris
limit
tidal
volum
adequ
high
peep
recruit
maneuv
open
lung
approach
special
situat
e
ratio
balanc
respiratori
rate
well
prone
posit
earli
prolong
recommend
specif
timet
fig
addit
neuromuscular
blockad
within
h
onset
ard
adequ
sedat
strategi
import
support
therapi
fig
bacteri
atyp
viral
fungal
specimen
bc
bal
infect
sourc
ct
scan
follow
broadspectrum
antiinfect
variou
techniqu
extracorpor
lung
support
discuss
recent
year
rescu
measur
sever
hypoxem
ard
specif
measur
scope
articl
describ
extens
elsewher
actual
mortal
rate
ard
patient
present
tabl
larg
recent
databas
ard
patient
countri
indic
differ
mortal
term
grade
sever
highest
mortal
rate
patient
sever
ard
